The dopamine metabolite aminochrome inhibits mitochondrial complex I and modifies the expression of iron transporters DMT1 and FPN1 - PubMed
The dopamine metabolite aminochrome inhibits mitochondrial complex I and modifies the expression of iron transporters DMT1 and FPN1
Pabla Aguirre et al. Biometals. 2012 Aug.
Abstract
Hallmarks of idiopathic and some forms of familial Parkinson’s disease are mitochondrial dysfunction, iron accumulation and oxidative stress in dopaminergic neurons of the substantia nigra. There seems to be a causal link between these three conditions, since mitochondrial dysfunction can give rise to increased electron leak and reactive oxygen species production. In turn, recent evidence indicates that diminished activity of mitochondrial complex I results in decreased Fe–S cluster synthesis and anomalous activation of Iron Regulatory Protein 1. Thus, mitochondrial dysfunction could be a founding event in the process that leads to neuronal death. Here, we present evidence showing that at low micromolar concentrations, the dopamine metabolite aminochrome inhibits complex I and ATP production in SH-SY5Y neuroblastoma cells differentiated into a dopaminergic phenotype. This effect is apparently direct, since it is replicated in isolated mitochondria. Additionally, overnight treatment with aminochrome increased the expression of the iron import transporter divalent metal transporter 1 and decreased the expression of the iron export transporter ferroportin 1. In accordance with these findings, cells treated with aminochrome presented increased iron uptake. These results suggest that aminochrome is an endogenous toxin that inhibits by oxidative modifications mitochondrial complex I and modifies the levels of iron transporters in a way that leads to iron accumulation.
Similar articles
-
Song N, Wang J, Jiang H, Xie J. Song N, et al. J Cell Biochem. 2010 Aug 1;110(5):1063-72. doi: 10.1002/jcb.22617. J Cell Biochem. 2010. PMID: 20564203
-
Protective and toxic roles of dopamine in Parkinson's disease.
Segura-Aguilar J, Paris I, Muñoz P, Ferrari E, Zecca L, Zucca FA. Segura-Aguilar J, et al. J Neurochem. 2014 Jun;129(6):898-915. doi: 10.1111/jnc.12686. Epub 2014 Mar 18. J Neurochem. 2014. PMID: 24548101 Review.
-
Cell death induced by mitochondrial complex I inhibition is mediated by Iron Regulatory Protein 1.
Urrutia PJ, Aguirre P, Tapia V, Carrasco CM, Mena NP, Núñez MT. Urrutia PJ, et al. Biochim Biophys Acta Mol Basis Dis. 2017 Sep;1863(9):2202-2209. doi: 10.1016/j.bbadis.2017.05.015. Epub 2017 May 11. Biochim Biophys Acta Mol Basis Dis. 2017. PMID: 28502703
-
Chinta SJ, Andersen JK. Chinta SJ, et al. Free Radic Biol Med. 2006 Nov 1;41(9):1442-8. doi: 10.1016/j.freeradbiomed.2006.08.002. Epub 2006 Aug 7. Free Radic Biol Med. 2006. PMID: 17023271
-
Nitrosylation and nitration of mitochondrial complex I in Parkinson's disease.
Chinta SJ, Andersen JK. Chinta SJ, et al. Free Radic Res. 2011 Jan;45(1):53-8. doi: 10.3109/10715762.2010.509398. Epub 2010 Sep 6. Free Radic Res. 2011. PMID: 20815786 Review.
Cited by
-
Impact of Plant-Derived Flavonoids on Neurodegenerative Diseases.
Costa SL, Silva VD, Dos Santos Souza C, Santos CC, Paris I, Muñoz P, Segura-Aguilar J. Costa SL, et al. Neurotox Res. 2016 Jul;30(1):41-52. doi: 10.1007/s12640-016-9600-1. Epub 2016 Mar 7. Neurotox Res. 2016. PMID: 26951456 Review.
-
On the Role of DT-Diaphorase Inhibition in Aminochrome-Induced Neurotoxicity In Vivo.
Herrera-Soto A, Díaz-Veliz G, Mora S, Muñoz P, Henny P, Steinbusch HWM, Segura-Aguilar J. Herrera-Soto A, et al. Neurotox Res. 2017 Jul;32(1):134-140. doi: 10.1007/s12640-017-9719-8. Epub 2017 Mar 11. Neurotox Res. 2017. PMID: 28285345
-
Teodorak BP, Scaini G, Carvalho-Silva M, Gomes LM, Teixeira LJ, Rebelo J, De Prá SD, Zeni N, Schuck PF, Ferreira GC, Streck EL. Teodorak BP, et al. Metab Brain Dis. 2017 Apr;32(2):557-564. doi: 10.1007/s11011-016-9936-5. Epub 2016 Dec 6. Metab Brain Dis. 2017. PMID: 27924409
-
Aminochrome induces dopaminergic neuronal dysfunction: a new animal model for Parkinson's disease.
Herrera A, Muñoz P, Paris I, Díaz-Veliz G, Mora S, Inzunza J, Hultenby K, Cardenas C, Jaña F, Raisman-Vozari R, Gysling K, Abarca J, Steinbusch HW, Segura-Aguilar J. Herrera A, et al. Cell Mol Life Sci. 2016 Sep;73(18):3583-97. doi: 10.1007/s00018-016-2182-5. Epub 2016 Mar 21. Cell Mol Life Sci. 2016. PMID: 27001668 Free PMC article.
-
Commentary: Evaluation of Models of Parkinson's Disease.
Muñoz P, Paris I, Segura-Aguilar J. Muñoz P, et al. Front Neurosci. 2016 Apr 19;10:161. doi: 10.3389/fnins.2016.00161. eCollection 2016. Front Neurosci. 2016. PMID: 27147953 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous